Sulfisoxazole |
Gantrisin |
Article: Sulfisoxazole
| Image:Sulfisoxazole.png | |
| Sulfisoxazole | |
| Systematic (IUPAC) name | |
| 4-amino-N-(3,4-dimethyloxazol-5-yl)- benzenesulfonamide | |
| Identifiers | |
| CAS number | 127-69-5 |
| ATC code | ? |
| PubChem | 5344 |
| DrugBank | APRD00595 |
| Chemical data | |
| Formula | C11H13N3O3S |
| Mol. weight | 267.305 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Sulfisoxazole is a sulfa drug based upon sulfonamide with a substituted oxazole.
It is sometimes given in combination with erythromycin or phenazopyridine.

Not Signed In -


